Owens & Minor, Inc. (NYSE:OMI) Shares Sold by Swiss National Bank

Swiss National Bank cut its holdings in Owens & Minor, Inc. (NYSE:OMI) by 3.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 136,500 shares of the company’s stock after selling 5,500 shares during the period. Swiss National Bank’s holdings in Owens & Minor were worth $1,784,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the business. Charles Schwab Investment Management Inc. grew its holdings in Owens & Minor by 13.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,305,043 shares of the company’s stock valued at $30,127,000 after buying an additional 276,807 shares during the period. JPMorgan Chase & Co. boosted its position in shares of Owens & Minor by 68.4% in the third quarter. JPMorgan Chase & Co. now owns 376,830 shares of the company’s stock worth $5,912,000 after acquiring an additional 152,999 shares during the last quarter. Barclays PLC grew its holdings in Owens & Minor by 354.8% in the third quarter. Barclays PLC now owns 133,702 shares of the company’s stock valued at $2,099,000 after purchasing an additional 104,305 shares during the period. Jane Street Group LLC grew its stake in shares of Owens & Minor by 126.0% during the 3rd quarter. Jane Street Group LLC now owns 186,280 shares of the company’s stock valued at $2,923,000 after buying an additional 103,871 shares during the period. Finally, FMR LLC increased its holdings in shares of Owens & Minor by 0.8% during the 3rd quarter. FMR LLC now owns 11,564,624 shares of the company’s stock worth $181,449,000 after buying an additional 90,862 shares during the last quarter. Hedge funds and other institutional investors own 98.04% of the company’s stock.

Owens & Minor Price Performance

Shares of OMI stock opened at $8.60 on Friday. Owens & Minor, Inc. has a twelve month low of $6.07 and a twelve month high of $28.35. The company has a market capitalization of $664.17 million, a PE ratio of -13.23, a price-to-earnings-growth ratio of 0.20 and a beta of 0.61. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11. The firm has a fifty day simple moving average of $9.84 and a 200-day simple moving average of $12.39.

Owens & Minor (NYSE:OMI) last announced its earnings results on Friday, February 28th. The company reported $0.55 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.02. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The company had revenue of $2.70 billion during the quarter, compared to the consensus estimate of $2.68 billion. During the same period last year, the firm earned $0.69 earnings per share. The company’s revenue was up 1.5% on a year-over-year basis. Equities research analysts anticipate that Owens & Minor, Inc. will post 1.51 earnings per share for the current fiscal year.

Owens & Minor declared that its board has approved a share repurchase program on Friday, February 28th that allows the company to repurchase $100.00 million in shares. This repurchase authorization allows the company to reacquire up to 13.6% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s board of directors believes its stock is undervalued.

Insiders Place Their Bets

In related news, major shareholder Coliseum Capital Management, L purchased 1,738,511 shares of Owens & Minor stock in a transaction dated Friday, February 28th. The shares were acquired at an average price of $9.39 per share, with a total value of $16,324,618.29. Following the completion of the transaction, the insider now owns 9,469,698 shares of the company’s stock, valued at approximately $88,920,464.22. This trade represents a 22.49 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.59% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on OMI shares. Robert W. Baird boosted their price target on Owens & Minor from $10.00 to $11.00 and gave the company a “neutral” rating in a research report on Monday, March 3rd. UBS Group decreased their target price on Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a report on Thursday, February 13th. Finally, JPMorgan Chase & Co. cut their target price on shares of Owens & Minor from $14.00 to $10.00 and set an “underweight” rating on the stock in a research note on Monday, March 10th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $13.75.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.